Skip to content
2000
Volume 19, Issue 26
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

This review highlights some recent advances in the design and development of matrix metalloproteinase inhibitors, especially those targeting MMP-2, MMP-9, and MMP-13. Various zinc-binding groups and non-zinc-binding groups are discussed. Interactions between residues in the critical S1' specificity pocket and MMP inhibitors are given special attention. The influence of ionization states of hydroxamates and retrohydroxamates on the docking outcome and the presence of zinc ions in the active site are explored in light of enhancing enrichment factors for docking studies. Details are given to structural factors for the development of more selective and more potent MMP inhibitors.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612811319260004
2013-08-01
2025-04-21
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612811319260004
Loading

  • Article Type:
    Research Article
Keyword(s): and zinc binding group; cancer; docking; MMP-13; MMP-2; MMP-3; osteoarthritis; rheumatoid arthritis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test